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Abstract
Background: Buruli ulcer (BU) caused by Mycobacterium ulcerans (M. ulcerans) has emerged as an important public health
problem in several rural communities in sub-Saharan Africa. Early diagnosis and prompt treatment are important in
preventing disfiguring complications associated with late stages of the disease progression. Presently there is no simple and
rapid test that is appropriate for early diagnosis and use in the low-resource settings where M. ulcerans is most prevalent.
Methodology: We compared conventional and pocket warmer loop mediated isothermal amplification (LAMP) methods
(using a heat block and a pocket warmer respectively as heat source for amplification reaction) for the detection of M.
ulcerans in clinical specimens. The effect of purified and crude DNA preparations on the detection rate of the LAMP assays
were also investigated and compared with that of IS2404 PCR, a reference assay for the detection of M. ulcerans. Thirty
clinical specimens from suspected BU cases were examined by LAMP and IS2404 PCR.
Principal Findings: The lower detection limit of both LAMP methods at 60uC was 300 copies of IS2404 and 30 copies of
IS2404 for the conventional LAMP at 65uC. When purified DNA extracts were used, both the conventional LAMP and IS2404
PCR concordantly detected 21 positive cases, while the pocket warmer LAMP detected 19 cases. Nine of 30 samples were
positive by both the LAMP assays as well as IS2404 PCR when crude extracts of clinical specimens were used.
Conclusion/Significance: The LAMP method can be used as a simple and rapid test for the detection of M. ulcerans in
clinical specimens. However, obtaining purified DNA, as well as generating isothermal conditions, remains a major challenge
for the use of the LAMP method under field conditions. With further improvement in DNA extraction and amplification
conditions, the pwLAMP could be used as a point of care diagnostic test for BU
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Introduction
Buruli ulcer (BU) caused by Mycobacterium ulcerans (M. ulcerans)i s
a necrotizing skin disease endemic mostly in rural wetland of
tropical countries of Africa, America, Asia and Australia. The
disease also occurs in non-tropical areas of Australia, China and
Japan. Globally, BU has been reported in over 30 countries [1–3].
The burden of BU is however most severe in sub Saharan Africa
where the true incidence of the disease is difficult to determine as a
result of poor surveillance measures and case confirmation [2].
Available data however reveals an increase in BU incidence over
the last several years in the west African countries of Ivory Coast,
Ghana and Benin. In these countries BU has replaced leprosy as
the second most prevalent mycobacterial disease [1], [3–5].
BU begins as painless nodule, papule, plaque or edema that
evolves into characteristic ulcers with undermined edges. If
untreated, extensive ulceration (that can cover 15% of the body),
scarring and contractures may cause serious functional disabilities
in patients [5–7].
Unfortunately most patients seek treatment late and present
with large ulcers [8–10]. Previously treatment of such lesions
involved surgical removal of all the affected tissue and part of the
surrounding tissues, eventually followed by skin grafting [9–12].
In 2004 antimycobacterial treatment alone (if necessary in
combination with surgery) was introduced and has since been
considered as the treatment of choice for BU [6], [13–16].
Laboratory confirmation of clinically suspected BU cases has
therefore become crucial for the clinical management of BU [17].
Four laboratory tests are recommended for the diagnosis of BU.
These include microscopic examination, culture, IS2404 PCR and
histopathological analysis. Microscopic examination detects 29%–
78% of clinically suspected BU cases and is currently the only
rapid and affordable test available for BU diagnosis in many
endemic areas. The detection rate of culture is between 34%–79%
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Culture therefore cannot be used for rapid laboratory confirma-
tion of BU. Histopathological analysis is reported to detect 30%
additional cases than other confirmatory tests, however this
technique is restricted to external reference laboratories and are
unavailable in peripheral health centres or district or regional
hospitals. IS2404 PCR has close to 96% sensitivity and is
considered the method of choice for laboratory confirmation of
BU [16–25].
The WHO recommends that at least 50% of cases must be
confirmed by IS2404 PCR before commencement of antibiotic
therapy [22–25].
However technical difficulties (eg, cold chain requirement,
stable power supply and qualified laboratory staff) limit the use of
this diagnostic test in BU endemic areas.
A dry reagent PCR consisting of lyophilized PCR mix which is
reconstituted with water for testing DNA was developed to
simplify BU diagnosis by PCR [26] but this method also requires
the use of a thermocycler, electrophoresis and gel imaging
equipment and therefore similarly makes the use of this diagnostic
test for BU diagnosis in endemic areas unlikely.
The Loop Mediated Isothermal Amplification (LAMP) is a
novel nucleic acid amplification method for molecular detection
and identification [27]. The principle of LAMP is autocycling
strand displacement DNA synthesis in the presence of Bst DNA
polymerase with high strand displacement activity under isother-
mal conditions between 60–65uC within 60 minutes [28]. The
assay is highly specific due to the recognition of target DNA by 4
to 6 independent sequences and the amplification efficiency of
LAMP is equivalent to that of PCR based methods ([27], [29],
[30]).
The LAMP reaction enables easy identification of positive tests
due to the accumulation of high amounts of amplification products
in the reaction tubes. Further improvement in visual identification
can be realized through the addition of intercalating dyes such as
SYBR green or hydroxynapthtol blue to reaction tubes [31]. This
therefore precludes the need for post amplification analysis and
hence reduces cost and labour. LAMP has also been shown to be
less affected by a number of inhibitors of conventional PCR [32].
Additionally the closed tube format of this assay reduces problem
of carry over contamination which is likely in less controlled
environments [33]. With all of these characteristics LAMP of
DNA has emerged as a powerful tool to facilitate point of care
diagnostic test [31].
In order to develop a field applicable technique that offers high
detection sensitivity and specificity for the diagnosis of BU, we
explored the use of the pocket warmer LAMP (pwLAMP)
technique, a DNA amplification method using isothermal
conditions (60uC) provided by a disposable pocket warmer [34].
Materials and Methods
Ethics statement
Ethical approval for analysing patients’ specimens was obtained
from the ethical review board of the Noguchi Memorial Institute
for Medical Research. Specimens used were anonymously taken
from an already existing collection of patients’ specimens
processed for diagnosis of BU from Agogo Presbyterian Hospital
in Ghana.
DNA from clinical specimens
Thirty clinical specimens consisting of 20 swabs and 10 fine
needle aspirates taken respectively from ulcers and pre-ulcerative
lesions of suspected BU patients were used in this study. The fine
needle aspirate specimens were kept in 1 ml phosphate buffered
saline (PBS) and swabs were stored dry in sterile tubes. Each swab
was transferred into a tube containing 2 ml milli-Q purified water
(Millipore Corporation, Billerica, MA) and gently vortexed for
5 sec and then removed. Portions 250 ml of the sample suspensions
were transferred to separate new sterile eppendorf tubes
containing 250 ml of lysis buffer (1.6 M GuHCl, 60 mM Tris
pH 7.4, 1% Triton X-100, 60 mM EDTA, Tween-20 10%), 50 ml
proteinase-K and 250 ml glass beads.
The mixtures were incubated horizontally in a shaker (200 rpm)
at 60uC overnight. To capture the DNA, 40 ml of diatomaceous
earth solution (10 g diatomaceous earth obtained from Sigma
Aldrich Chemi GmbH in 50 ml of H2O containing 500 ml of 37%
(wt/vol) HCl) was added to the suspensions and incubated at 37uC
with shaking (200 rpm) for 60 min. The mixtures were centrifuged
at 14,000 rpm for 10 sec and the resulting pellets were washed
twice with 900 ml of 70% ethanol (2–8uC) followed by 900 mlo f
acetone. The pellets were dried at 50uC for 20 min and
resuspended in 100 ml milli Q purified water and centrifuged at
14,000 rpm for 10 sec. The purified DNA was used as templates
for both IS2404 PCR and LAMP assays to detect M. ulcerans.
To investigate the performance of the LAMP assay on crude
DNA preparations, we obtained 2 types of DNA extracts for each
clinical specimen. One crude extract consisted of 250 ml
suspensions of the specimen boiled for 10 min followed by
centrifugation at 14,000 rpm for 5 min (boiled extract). The other
crude extract used was a 250 ml suspension of the unboiled
specimen.
Detection limit of LAMP
Ten M. ulcerans strains grown on LJ slants were harvested and
DNA was extracted as previously described [35]. Serial dilutions of
purified M. ulcerans DNA containing 300,000, 30,000, 300, 30 and
3 copies of IS2404 element per 5 ml were prepared. The number
of copies of the insertion sequence element was determined based
on the genome size of 5,806 kb and presence of an average
number of 207 copies of IS2404. This was used to determine the
detection limit of the LAMP assays.
Author Summary
In order to develop a simple and rapid test that can be
used to diagnose Buruli ulcer under field conditions, we
modified the conventional LAMP assay by using a
disposable pocket warmer as a heating device for
generating a constant temperature for the test reaction
and employed the use of crude sample preparations
consisting of boiled and unboiled extracts of the clinical
specimen instead of using purified DNA as the diagnostic
specimen. Thirty clinical specimens from suspected Buruli
ulcer patients were investigated by the modified LAMP (or
pocket warmer LAMP) and the conventional LAMP, as well
as IS2404 PCR, a reference method for the detection of
Mycobacterium ulcerans. There was no significant differ-
ence in the detection rate (63–70%) in all of the methods
when purified samples were used for the tests. On the
other hand the use of crude specimen preparation
resulted in a drop in detection rate (30–40%). This study
demonstrates that the LAMP test can be used for rapid
detection of M. ulcerans when purified DNA preparations
are used. With further improvements in the sample
reaction, as well as in specimen purification, the pocket
warmer LAMP may provide a simple and rapid diagnostic
test for Buruli ulcer.
LAMP for Detection of Mycobacterium ulcerans
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PCR targeting IS2404 was performed as described previously
[21]. The first and second round PCRs used primers pGp1: 59-
AGGGCAGCGCGGTGATACGG-39and pGp2: 59- CAGTG-
GATTGGTGCCGATCGAG-39 and pGp3: 59-GGCGCAGAT-
CAACTTCGCGGT-39 and pGp4: 59-CTGCGTGGTGCTTT-
ACGCGC-39, respectively.
For the First round, the 30 ml reaction volume contained 3 ml
DNA, 25 pmol/ml of each primer (pGp1 and pGp2), 3 mlo f1 0 6
PCR buffer (containing 1.5 mM magnesium chloride), 6.0 mlQ -
solution, 0.2 mM deoxynucleotide triphosphates (dNTPs) and
1.0 U HotStar Taq polymerase (QIAGEN).
For the second run, 1 ml of the first run product was added to
24 ml reaction volume containing, 25 pmol/ml of each primer
(pGp3 and pGp4), 2.5 mlo f1 0 6 PCR buffer, 5.0 ml Q-solution,
0.2 mM dNTPs and 1.0 U HotStar Taq polymerase. Amplifica-
tion for both rounds for 40 and 35 cycles respectively was carried
out in an Eppendorf mastercycler thermal cycler as follows:
denaturation at 95uC for 15 min, 94uC for 30 sec, 64uC for 1 min,
72uC for 1 min, 30 sec and a final extension at 72uC for 10 min.
The second round PCR products were electrophoresed in a 2%
TAE (0.04 M Tris-acetate and 0.001 M EDTA pH 8.0) agarose
gel with ethidium bromide. The size of amplicons was estimated
by comparison with 100 bp plus DNA ladder (Fermentas Life
Sciences, EU) and visualized using Kodak Gel logic 100 Molecular
Imaging System.
LAMP
The LAMP assay was performed using a set of 6 primers
comprising 2 outer primers (Buruli- F3: CGAGAACAGCCTG-
CACTG, and Buruli- B3: CGGTTGGCGGTCAAAGC).
Two inner primers (Buruli-FIP:GTGCGCCGTGTCCGG-
TATGGATACGCGATGTCACCTTC and Buruli- BIP: AGG-
TCCTAGCAACGCTACGCAAATCCGGCAGGCTTCGG), 2
loop primers Buruli-LF: GCCTTTGACGGTCTTCGTC, and
Buruli- LB: (CACCGCGATCAATCTGCAC). The primers were
designed using Primer Explorer (version 4; EikenChemical,
Tokyo, Japan; http://primerexplorer.jp/elamp4.0.0/index.html).
Pocket warmer LAMP (pwLAMP) was performed using a
loopamp DNA amplification kit (Eiken Chemical) described
previously [32]. Each 25 ml reaction mixture contained 1.6 mM
each of FIP and BIP, 0.2 mM each of F3 and B3, 0.8 mM each of
LF and LB, 26 reaction mixture (12.5 ml), 1 mlo fBst DNA
polymerase, 1 ml of fluorescence detection reagent (Eiken
Chemical), 3.5 ml distilled water and 1 ml sample.
Reaction tubes were incubated at 60uC for 60 min in the heat
block (GeneAmp 9700, Applied Biosystems, Foster City, CA) while
with the pwLAMP, the tubes were sandwiched in a twofold pocket
warmer (Hokaron Haru-type, Lotte Health Products, Tokyo,
Japan) surrounded by a paper towel, and put in a Styrofoam box
for 120 min (60 min reaction incubation). The reaction was
terminated at 85uC for 5 min and the results were read by eye in
ambient light and also using UV illumination.
Figure 1. Specificity of Loop mediated isothermal amplification (LAMP) for Mycobacterium ulcerans. Conventional (upper, heat block) and
pw-LAMP (lower, pocket warmer). Fluorescence image under the UV light are shown. Lanes; 1; Mycobacterium ulcerans,2 ;Mycobacterium marinum,3 ;
Mycobacterium shinsuense,4 ;Mycobacterium tuberculosis,5 ;Mycobacterium avium,6 ;Mycobacterium intracellularie,7 ;Mycobacterium kansasii,8 ;
Mycobacterium abscessus,9 ;Mycobacterium chelonae, 10; Mycobacterium ulcerans, 11; Mycobacterium ulcerans and 12; Jurkart cell line.
doi:10.1371/journal.pntd.0001590.g001
Table 1. Comparison of IS2404 PCR with pocket warmer LAMP for the detection of Mycobacterium ulcerans using different DNA
templates.
Pocket warmer LAMP
Unboiled extract Boiled extract Purified extract
(+)( 2) Total (+)( 2) Total (+)( 2) Total
IS2404 PCR (+)1 29 2 1 9 1 2 2 1 1 9 2 2 1
IS2404 PCR (2) 0 99 0 99 0 99
Total 12 18 30 9 21 30 19 11 30
Positivity 40% 30% 63.3%
*Sensitivity 100% 100% 90.5%
*Sensitivity as compared with IS2404 PCR.
LAMP (Loop mediated isothermal amplification).
doi:10.1371/journal.pntd.0001590.t001
LAMP for Detection of Mycobacterium ulcerans
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DNA extracts of eight Mycobacterium sp. (Mycobacterium marinum,
Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracel-
lulare, Mycobacterium kansasii, Mycobacterium abscessus, Mycobacterium
chelonae), two Mycobacterium ulcerans strains (Mycobacterium shinsuence
(Japanese strain) and one (African strain)) and Jurkat (human T cell
line) were examined.
Statistical analysis
A chi-squared test was performed to reveal the statistical
difference using SPSS (version 16.0; SPSS Inc., Chicago, IL)
software.
Results
Detection limit of LAMP for M. ulcerans
LAMP reaction requires a constant temperature of about 60u–
65uC for 60 min for amplification of DNA [27–34]. In a previous
study a pocket warmer reached 58uC in 30 min and stayed around
60uC for more than 60 min in a Styrofoam box [34]. The 3 pocket
warmers (of a pack of 30 hand warmers) tested in this study
achieved a temperature of 60uC after 60 min and maintained this
temperature for about 90 min. The pocket warmer thus provided
a suitable temperature (60uC) and time range (60 min) for
amplification. Both pwLAMP and the conventional LAMP assays
were able to detect to the limit of 300 copies of the target sequence
after 60 min of amplification. This limit improved to 30 copies
when the conventional LAMP was carried out at 65uC (the pocket
warmer was not able to attain this temperature and was therefore
not investigated).
Specificity of pwLAMP for M. ulcerans
Observation under ambient as well as UV illumination
demonstrated clearly that the LAMP reaction produced positive
signal specifically in DNA from M. ulcerans, but not in DNA
extracts of M. marinum, M. tuberculosis, M. avium, M. intracellularie, M.
kansasii, M. abscessus, M. chelonae, and Jurkart, a human T cell line
(Figure 1).
Comparison of LAMP with IS2404 PCR
The sensitivity and specificity of the LAMP assays for the
detection of M. ulcerans is shown in tables 1 and 2. Under ambient
illumination, positive specimens in the LAMP assay produced
greenish colouration (Figure 2). When purified DNA extracts were
used, 21 (16 swabs, 5 fine needle aspirates) (70%) of 30 clinical
specimens were positive by IS2404 PCR as well as by the
conventional LAMP. None of the PCR positive specimens were
negative by conventional LAMP. However 19 samples of purified
DNA extracts were positive with the pwLAMP, but the 90.5%
sensitivity (19/21) of the pwLAMP compared to the results by
IS2404 PCR was not statistically significant (p=0.58, Chi-square
test).
All negative specimens in IS2404 PCR were negative in both
LAMP assays, indicating specificities of both LAMP assays to the
reference method were 100%. Twelve unboiled (9 swabs and 3
fine needle aspirates) and 9 boiled (6 swabs and 3 fine needle
aspirates) extracts were positive by all 3 detection assays with
sensitivities of 57.1% (unboiled, 12/21) and 42.9% (boiled, 9/21)
compared to results using purified DNA extracts respectively for
both LAMP and IS2404 PCR assays. The positivity of swabs was
found to be in the range of 30% to 80% compared to 30% to 50%
for fine needle aspirates.
When the positivities in crude DNA specimens were compared
with those in purified DNA, the differences were statistically
significant by chi-square test (unboiled vs purified DNA,p=0.0195,
and boiled vs purified DNA, p=0.0019). None of the IS2404 PCR
negatives was positive in the LAMP assays irrespective of the DNA
extracts type used. These data suggest that sensitivity of LAMP and
PCR assays for the detection of M. ulcerans in clinical specimens is
enhanced when purified DNA extracts are used.
Discussion
BU is a neglected tropical disease that mostly affects the poor in
resource limited communities in sub-Saharan Africa [1–3].
Table 2. Comparison of IS2404 PCR with conventional LAMP for the detection of Mycobacterium ulcerans using different DNA
templates.
Conventional LAMP
Unboiled extract Boiled extract Purified extract
(+)( 2) Total (+)( 2) Total (+)( 2) Total
IS2404 PCR (+)1 2 92 1 9 1 2 2 1 2 1 02 1
IS2404 PCR (2) 0 99 0 99 0 99
Total 12 18 30 9 21 30 21 9 30
Positivity 40% 30% 70%
*Sensitivity 100% 100% 100%
*Sensitivity as compared with IS2404 PCR
LAMP (Loop mediated isothermal amplification).
doi:10.1371/journal.pntd.0001590.t002
Figure 2. Detection of Mycobacterium ulcerans under ambient
illumination. Tubes containing M. ulcerans DNA produced greenish
fluorescence (tubes 1–4).
doi:10.1371/journal.pntd.0001590.g002
LAMP for Detection of Mycobacterium ulcerans
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diagnosis cannot be operational in BU endemic areas
[16],[17],[24–25].
The development of rapid and reliable point of care diagnostic
assays is of high priority to BU management and prevention.
This study explored the potential use of the LAMP method for
field diagnosis of BU. Some important limitations to the use of this
assay in the field include specimen purification and difficulty in
maintaining isothermal condition for the reaction. A study
suggested that omission of DNA extraction or the use of crude
DNA extracts have no effect on the LAMP test [32]. Hatano et al
used a disposable pocket warmer to provide isothermal condition
for LAMP reaction [34].
Based on this knowledge, we applied the pwLAMP to crude and
purified DNA extracts in order to determine whether this method
will be suitable for use as a point of care diagnostic test for BU.
Although the pocket warmers used in this study reached 60uC
after 1 hr (instead of 30 min in previous studies [34]), both devices
achieved the requisite temperature and holding time for executing
LAMP reaction, a major advantage in the use of amplification
based assay for the detection of an infectious agent under field
condition. The pwLAMP did not cross-react with other myco-
bacteria (Figure 1). Moreover, the experiment on clinical
specimens demonstrated that the pwLAMP had a 100% specificity
in clinical specimens of BU.
The pwLAMP was found to have comparable sensitivity as the
conventional LAMP at 60uC as both assays were able to detect
300 copies of IS2404 element (equivalent of 1.5 genomes of M.
ulcerans). The detection limit of the conventional LAMP at 65uC
improved to 30 copies of IS2404 and this level of sensitivity may
probably be achieved with a pocket warmer that can attain a
temperature of 65uC and maintain a holding time of 60 min.
When applied to purified DNA extracts of clinical specimens, the
pwLAMP, conventional LAMP and IS2404 PCR yielded
concordant results (Tables 1 and 2).
However, 2 of the samples that were positive by IS2404 PCR/
conventional LAMP were negative by the pw LAMP. None of the
IS2404 PCR negative samples were positive in both types of
LAMP assays. On the other hand we observed a drop in detection
rate from 63–70% to 30–40% when crude extracts of clinical
specimens were used (Tables 1 and 2).
This indicates that the use of crude DNA extracts as template
may not be appropriate for the detection of M. ulcerans by the
LAMP method. This observation contradicts a previous study that
suggested omission of DNA extraction had no effect on sensitivity
of the LAMP assay [32].
For the crude preparations however, it is noteworthy that the
detection rate of the LAMP assay was significantly higher for the
unboiled extracts than for the boiled extracts. Explanations for
these results were not explored. The observation that the LAMP
assay was not inhibited especially for the unboiled specimens is
quite consistent with previous work that have shown LAMP to be
tolerant to culture medium and to certain biological substances
including phosphate buffered saline, serum, plasma, urine and
vitreous [32].
In conclusion, the study demonstrates that the LAMP assay
yields comparable results as IS2404 PCR when it is performed at
60u–65uC for 60 min on purified DNA extracts and further
supports the use of the pocket warmer as a device for providing
isothermal amplification condition for the LAMP assay. This
therefore is a potential boost to the application of pwLAMP in
resource poor settings.
Challenges of obtaining pure DNA extracts of clinical specimen
as well as the use of a pocket warmer capable of maintaining 65uC
for 1 hr, however needs to be addressed in order to improve the
performance of the pwLAMP assay.
Further development and testing in larger numbers of
specimens is therefore necessary to access the potential use of
pwLAMP as a simple and rapid point of care diagnostic test for
BU.
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